www.fdanews.com/articles/86036-aspreva-sees-1q-revenue-of-62-million
ASPREVA SEES 1Q REVENUE OF $62 MILLION
April 13, 2006
Pharmaceutical company Aspreva Pharmaceuticals
Corp. said Thursday it expects to report first-quarter revenue of about $62 million,
aided by a higher-than-expected payment under its collaboration agreement with
Roche Holding Ltd.
Business
Week